Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · June 13, 2023

Systemic Adverse Events Among Patients With Diabetes Treated With Intravitreal Anti-VEGF Injections

JAMA Ophthalmology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Ophthalmology
Systemic Adverse Events Among Patients With Diabetes Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections
JAMA Ophthalmol 2023 Jun 01;[EPub Ahead of Print], S Zafar, A Walder, S Virani, K Biggerstaff, S Orengo-Nania, J Chang, R Channa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading